Industry Analysis Reports | Health Care | Medical Devices

Tuesday, 2 March 2021

Epilepsy Diagnosis & Treatment Market Global Opportunities, Development Status, Sales Revenue and Forecast 2023

Market Highlights

Increasing prevalence of epilepsy, rising number of traumatic brain injury cases, growing geriatric population, and rising healthcare expenditures are the major drivers for the global epilepsy diagnosis and treatment market. However, high cost of therapeutic surgeries, low per capita healthcare expenditure, and lack of awareness for the disease in emerging economies are estimated to restrain the market growth during the projected period. The global epilepsy diagnosis and treatment market is estimated to grow at an approximate CAGR of 6.3% during the forecast period.

Segmentation

The global epilepsy diagnosis and treatment market is segmented on the basis of type, diagnosis, treatment, and end-user. On the basis of type, the market is segmented into idiopathic, cryptogenic, symptomatic, and others. On the basis of diagnosis, the market is segmented into neurological exam, blood test, imaging, and others. The imaging segment is sub-segmented into electroencephalogram, computerized tomography, magnetic resonance imaging, positron emission tomography, and others. On the basis of treatment, the market is segmented into medication, surgery, brain stimulation, and others. The medication segment is sub-segmented into acetazolamide, carbamazepine, clobazam, and others. The surgery segment is sub-segmented into hemispherectomy, corpus callosotomy, resection surgery, and others. The brain stimulation segment is sub-segmented into deep brain stimulation, responsive neurostimulation, and others. On the basis of end user, the market is segmented into hospitals & clinics, diagnostic centers, and others.

Access Report Details @ https://www.marketresearchfuture.com/reports/epilepsy-diagnosis-treatment-market-5647

Regional Analysis

The Americas dominate the global epilepsy diagnosis and treatment market, which can be attributed to the presence of a well-developed healthcare sector and huge patient population within the region. Moreover, increasing number of head trauma cases boosts the American market. Europe holds the second largest market share owing to the availability of funds for research, presence of a well-developed healthcare sector, and government support. Followed by Europe, the Asia Pacific region is projected to be the fastest growing region for the global epilepsy diagnosis and treatment market. Presence of developing healthcare sector, along with emerging economies of the Asia Pacific region boosts the market growth. The Middle East & Africa has the least share in the global epilepsy diagnosis and treatment market, owing to the low per capita healthcare expenditures, lack of awareness for the disease, and stringent government policies, especially in the African region. On the other hand, the Middle East region within the Middle East & Africa is estimated to be fastest growing region due to growing healthcare expenditures and presence of the developed economies, such as Kuwait, Qatar, Dubai, and others.

Key Players

The key players for the global epilepsy diagnosis and treatment market are Pfizer, Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), UCB Pharma Ltd. (U.K), Abbott (U.S.), GlaxoSmithKline plc (U.K), Novartis International AG (Switzerland), Sanofi S.A. (France), Shire (Republic of Ireland), Medtronic (U.S.), NeuroWave Systems Inc. (U.S.), Natus Medical Incorporated. (U.S.), Siemens Ltd. (Germany), and others

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

Nurse Call System Market 2021 Size, Share, Growth, COVID-19 Impact Analysis, Business Opportunities, Demand by Major Companies

Market Scenario:

Nurse call systems are alert healthcare professionals such as nurses of a fore coming event such medical emergency or request for care from a patient or ambulatory services. Nurse call systems can also track and record a patient’s movements such as those in assisted living centers.

Segments:

To generate an accurate assessment of the differential market potential, the Nurse Call System Market is divided by type, technology, applications and end users.

Type - basic buttons alert systems, audio/visual nurse call systems, integrated communication systems, mobile systems, others.

Technology - wired systems and wireless systems, application (medical emergency, alarms, workflow management and others.

Application - medical emergency, alarms, workflow management and others.

End user - hospitals and clinics, assisted living centers, ambulatory, and other.

Future Market Trends:

The triumph of wireless systems over wired systems!

Wireless systems are expected to eliminate wired systems, a trend that has been witnessed in the past and which is very much prevalent in present communication technology.

Access Report Details @ https://www.marketresearchfuture.com/upcoming-reports/nurse-call-system-market-5631

Extended functionality

Extended functionality owing to technological convergence is ubiquitous in every segment of information technology and electronics industry and the nurse call systems market is no exception to this trend.

Market Dynamics:

Drivers

The demographic drivers of the market are the growth in elderly, growing chronic diseases, growing number of widowed or separated people, growing per capita income, growing assisted living centers and others.

The operational drivers include the growing complexity of hospital operations, the low flexibility of demand of the operations, growing regulations, prohibitive costs of noncompliance and others.

Technological drivers of the market include growing connectivity such as coverage of network and mobility, falling cost of devices, negligible cost of scalability of communication technology and others.

Restraints

The market constraints are high installation and maintenance costs, lack of awareness and scarcity of trained manpower, concerns of information security due to open nature of the network, and others.

Regional analysis:

North America led by the U.S. commands the largest market share due to the well-developed healthcare infrastructure, faster uptake of new technology, large number of hospitals and high per capita income and others.

North America is anticipated to withhold a market share by value of approximate 40 % in 2016 followed by Europe with a share of over 30 %.

Asia Pacific region is estimated to grow at the fastest CAGR led by Japan, china, India and South Korea. The market of the Middle East & African region, is expected to be heavily skewed in favour of the Gulf economies of Saudi Arabia, UAE and others. Africa is expected to foresee moderate growth due to poor connectivity and economic reasons.

Prominent players:

The prominent players in the market are Ascom Holding AG, Tyco International PLC, CSINC, Austco Communication Systems Pty Ltd., Hill-Rom Holdings, Inc., Honeywell International, Inc., and others.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Breast Imaging Market, Industry Segments, Growth, Trends, Demand, Outlook by 2023

Market Synopsis

The global breast imaging market is considered to demonstrate 8.5% CAGR during the forecast period (2017-2023) owing to increasing prevalence of breast cancer, asserts Market Research Future (MRFR). Breast imaging is referred to a diagnostic procedure which evaluates the presence of breast tumor in women. Breast biopsy ultrasound, mammography, PET, CT, MRI, tactile imaging, and others are some of the common breast imaging procedures. Among these, mammography is the most widely used screening tool and diagnosis for breast cancer and helps to detect breast cancer at an early stage. According to the World Health Organization, breast cancer has been reported as the second most common cancer among the women population.

Get Free Sample Copy@ https://www.marketresearchfuture.com/sample_request/5612

Drivers and Constraints Impacting the Market

With the rising prevalence of breast cancer, the global breast imaging market is anticipated to flourish during the assessment period. More than 200,000 new cases of cancer are diagnosed every year across the globe. The increasing expenditure on healthcare by the developed countries coupled with the technological developments in the field of oncology across the world has further contributed to the market growth. Moreover, the emergence of new imaging technologies for screening and diagnosis of several chronic diseases have influenced the market growth to a great extent. Several companies conduct corporate social responsibility activities to help women educate regarding breast health and its preventive measures. For instance, companies like GE Healthcare have recently launched a commercial regarding the awareness of breast density and its effect on screening techniques. With the increasing awareness, the demand for breast imaging is predicted to expand in during the appraisal period.

On the flip side, the high cost of breast imaging solutions coupled with the unawareness about breast imaging among the women population are predicted to dampen the market growth during the estimated period. Moreover, most of the women are reluctant to undergo breast imaging owing to a number of misconceptions about the disease. This is considered to restrict the market growth in the coming years.

Global Breast Imaging Market: Segmental Analysis

The global breast imaging market has been segmented on the basis of type, application, deployment, end-user, and region.

By mode of type, the global breast imaging market has been segmented into CT, mammography, MRI, PET, breast biopsy, ultrasound, tactile imaging, and others. Among these, the mammography segment has been further sub-segmented into full-field digital mammography (FFDM), film-screen mammography, scintimammography or molecular breast imaging, 3D mammography, and others. The breast biopsy segment has been sub-segmented into tactic core biopsy, image-guided breast biopsy, ultrasound-guided core biopsy, and others.

By mode of application, the global breast imaging market has been segmented into post-neoadjuvant chemotherapy, breast cancer diagnosis, metastatic axillary adenocarcinoma, and others.

By mode of end-user, the global breast imaging market has been segmented into diagnostic centers, hospitals, and others.

Regional Insights

Geographically, the breast imaging market span across regions namely, America, Asia Pacific, Europe, and the Middle East & Africa.

Among all the regions, America is considered to be the largest market for breast imaging. The growth is attributed to the growing prevalence for breast cancer, innovative imaging solutions for breast imaging, and development of new imaging devices by the major market players. The market in the North American region is driven by the extensive use of imaging modalities like CT, mammography, and MRI for screening of breast cancer. The U.S. is considered to hold the largest market share owing to the presence of major players coupled with emphasis on women healthcare.

The European market is presumed to exhibit a significant growth owing to an increased expenditure on research and development activities by the major countries like U.K. The market in Germany is expanding at a substantial rate owing to an extensive use of available imaging technologies for breast imaging coupled with the exponential growth of medical devices industry. Moreover, the urge of developing new imaging devices for early cancer screening is also considered to contribute to the market growth in this region.

The Asia Pacific region showcases numerous growth opportunities owing to the presence of some of the largest contributors such as China, Japan, and India. With rising awareness about breast cancer along with the use of medical devices for cancer screening, the breast imaging market is likely to accelerate in this region. Moreover, the rapid growth of healthcare imaging industry in China and India and rising government support for improvement in the diagnostic services and healthcare infrastructure contributes to the market growth.

Industry Updates

December 04, 2018: The Ultrasound Breast Imaging Center has opened in Walnut Creek. This ultrasound 3D breast imaging involves no compression, no radiation, and no injections.

Also Read Here!! https://www.medgadget.com/2021/02/breast-imaging-market-industry-analysis-2021-global-size-technology-demand-growing-segments-revenue-share-and-foster-market-growth-by-2025.html

Competitive Dashboard

The prominent players operating the global breast imaging market are Sonocine Inc. (U.S.), Fujifilm Holdings Corporation (Japan), General Electric Company (U.K.), Hologic Inc. (U.S.), Dilon Technologies Inc. (U.S.), Gamma Medica Inc. (U.S.), Toshiba Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Siemens (Germany), Aurora Imaging Technology Inc. (U.S.), and others.

Access Report Details @ https://www.marketresearchfuture.com/reports/breast-imaging-market-5612

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Coma Diagnosis & Treatment Market: Emerging Technologies, Competition & Strategies of Key Players, Regional Analysis and Forecast By 2023

Market Highlights

There is no particular treatment that can cause someone to come out of a coma and treatments can prevent further physical and neurological damage. However depending on the cause of a coma, patient who are continuosly in this state for more than one year are extremely unlikely to awaken.

Over the last decade, the number of hospitals has increased to a great extent, which has influenced the growth of the market positively. Moreover, increasing demand for better treatment and changing reimbursement policies have fueled the market growth.

Increasing prevalence of neurological/brain disorder like epilepsy, rising need for better treatment, increasing investment of biotechnology and pharmaceutical industries in R&D, and availability of funds drive the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapid development in technology will fuel the market growth during the forecast period. On the other hand, higher cost of the treatment procedure may slow the market growth during the review period.

The global coma diagnosis & treatment market is expected to grow at a CAGR of ~7.1% during the forecast period 2017-2023.

Regional Analysis

The Americas dominate the global coma diagnosis & treatment market owing to the presence of huge patient population, high health care spending, and increasing government support for research & development.

Europe holds the second largest share of the global market. The increasing focus of various government agencies on treating various brain disorders or brain injuries such as epilepsy, and depression will have a positive impact on the growth of the market. The growing public awareness will boost the adoption of these devices in the European market.

Asia Pacific is the fastest growing coma diagnosis & treatment market across the globe. Japan holds the major share of the regional market due to availability of technology and huge healthcare spending. Rapidly developing economy, increasing healthcare expenditure, and government initiatives for research & development will drive the market in China and India over the assessment period.

The Middle East and Africa hold the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.

You can also Read @ https://www.medgadget.com/2018/08/coma-diagnosis-and-treatment-market-anticipated-to-witness-noteworthy-growth-in-the-coming-years.html

Segmentation

The global coma diagnosis & treatment market is segmented on the basis of types, diagnosis, treatment, and end user. On the basis of the type, it is segmented into toxic- metabolic encephalopathy, anoxic brain injury, persistent vegetative state, locked-in syndrome, and brain death. On the basis of diagnosis it is segmented into physical examination, blood test, brain scans, and others. Brain scan is further segmented into computerized tomography (CT) scan, magnetic resonance imaging (MRI) and electroencephalography (EEG). On the basis of treatment it is segmented into medical treatment, and others. On the basis of the end user, it is segmented into hospitals & clinics, research laboratories and others.

Key Players

Some of key the players in the market are Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others.

Browse Full Report @ https://www.marketresearchfuture.com/reports/coma-diagnosis-and-treatment-market-4990

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Monday, 1 March 2021

Phototherapy Market Analysis, Industry Growth, Demand, Size, Share, Opportunities and Regional Forecast 2027

Phototherapy Market Analysis

The global phototherapy market is eyeing for a prodigious growth at a stellar 4.6% CAGR over the predicted years (2017-2023). Phototherapy or light therapy includes skin exposure to ultraviolet (UV) light under medical supervision. Some of the most widely used phototherapy techniques include Psoralen + UVA (PUVA), narrow-band UVB (NBUVB) and Ultraviolet A (UVA)/NBUVB (together). The phototherapy technique used will rest on the skin condition type. This treatment uses special light which helps to increase the production of vitamin D, calm inflammation, reduce itch, ramp up the bacteria-fighting systems and also treat various skin diseases namely jaundice, vitiligo, psoriasis, dermatitis, eczema and others. Apart from this, phototherapy is also used to treat newborns that suffer from jaundice. During this procedure the neonates will be exposed towards the fluorescent light that will help them in recovering faster.

Request a Sample Copy to Understand the Impact of COVID-19 On Phototherapy Market @ https://www.marketresearchfuture.com/sample_request/1844

There are several factors that is propelling the growth of the phototherapy market These factors according to the Market Research Future (MRFR) report include increasing cases of neonatal jaundice, increasing incidences of people having skin diseases, availability of products that are technologically advanced, increasing use of phototherapy equipment that is LED-based, increasing awareness amid patients concerning advanced treatment options, improved infrastructure and healthcare service, introduction of home use phototherapy equipment, growing urbanization, changing lifestyle, increasing investments in research and development activities and ample benefits of phototherapy. On the contrary factors such as strict regulatory policies for new device approval, significant utilization of alternative treatment mode, unmet medical needs and risks associated in the treatment may impede the growth of the phototherapy market. The risks that are associated to this treatment include childhood seizures, cataracts from inadequate eyewear at the time of the treatment, nausea and headache with PUVA treatment, melanoma, skin aging and sunburn.

Phototherapy Market Segmentation

Market Research Future report offers a comprehensive segmental analysis of the phototherapy market on the basis of devices, indication and end-user.

Based on devices, it is segmented into fiber-optic band, fiber-optic blanket, firefly and others.

Based on indication, the phototherapy market is segmented into jaundice, skin diseases and others. The skin disease is further segmented into vitiligo, psoriasis and others. Of these, skin diseases will have the largest share in the market.

Based on end user, it is segmented into home care, dermatology center, hospitals and clinics and others. Of these, the hospitals and clinics segment will dominate the market.

Phototherapy Market Regional Analysis

Based on region, the phototherapy market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Rest of the World. Of these, North America will remain at the forefront in the phototherapy market over the predicted years due to increasing incidences of jaundice in infants, changing lifestyle, high healthcare expenditure, increasing support from the government for R&D activities, well-developed technology and concentration of key players in the region. Europe has the second biggest share in the market that is followed by the APAC region. Strong government support and accessibility of funds especially for R&D is fueling the growth of the market. France and Germany are increasing investment within the healthcare sector. In the APAC region the phototherapy market will grow at the fastest pace due to increasing need for novel treatments in countries such as South Korea and India, increasing government support, rapidly developing economy and increasing healthcare awareness. In the Middle East and Africa, the phototherapy market will have minimal share owing to limited accessibility of medical facilities and funds and poor political conditions particularly in Africa. The photography market in the Middle East and Africa is being led by the Middle East owing to the existence of well-developed countries such as South Arabia, Oman, Qatar and Kuwait. The Africa region is predicted to have a promising growth owing to immense opportunity for market development.

Phototherapy Market Competitive Analysis

The phototherapy market is competitive and fragmented. The key players are engaging in various strategies namely new product launch, mergers and acquisitions and also regional expansions for catering the unmet requirements of the target population.

Key Players

The key players profiled in the phototherapy market include VIA Global Health (U.S.), MTTS ASIA (Vietnam), PhotoMedex, Inc (U.S.), Herbert Waldmann GmbH & Co. KG (Germany), Beurer GmbH (Germany), Natus Medical Incorporated (U.S.), Koninklijke Philips N.V. (the Netherlands), and GE Healthcare (UK).

Dec 2018 - Scientists at Northwestern’s McCormick School of Engineering and Northwestern Medicine has developed the world’s smallest wearable device which is battery-free for measuring light exposure across various wavelengths including visible, UV (ultra violet) and also the solar spectrum’s infrared parts. This device can record three different wavelengths of time simultaneously. It weighs as tiny as a raindrop, can be mounted on a watch, sunglass or hat, it is sans interfaces or switches, and will interact with the phone wirelessly.

Browse Complete Report with Niche Segments and Top Industry Players at https://www.marketresearchfuture.com/reports/phototherapy-market-1844

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Regional demand on Seasonal Affective Disorder Market Analysis, size, News and Forecast

Seasonal Affective Disorder Market Analysis

The global seasonal affective disorder market is predicted to touch USD 694.9 million at a 4.2% CAGR by 2023, as per the latest Market Research Future (MRFR) report. Seasonal affective disorder or SAD is a form of depression which is associated with changes in seasons. It starts as well as ends within the same time of the year. Social withdrawal, loss of ability to concentrate, weight gain, increased appetite, and hopelessness are some of its major symptoms.

Get FREE Sample PDF (including COVID19 Impact Analysis) of Market Report @ https://www.marketresearchfuture.com/sample_request/4123

Various factors are propelling the seasonal affective disorder market growth. These factors, in accordance with the MRFR report, include growing awareness and increasing prevalence of the seasonal affective disorder, rising physician visits associated to this disorder, lack of exercise, changing lifestyle, and adoption and availability of new seasonal affective disorder treatments. Additional factors pushing market growth include an increase in geriatric population, technological development, improved distribution network, and favorable reimbursement scenario.

On the contrary, higher preference for light therapy and expanding market for generic drugs are factors that may hinder the seasonal affective disorder market growth.

Seasonal Affective Disorder Market Segmentation

The MRFR report provides a complete segmental analysis of the seasonal affective disorder market report on the basis of type, treatment, diagnosis, and end user.

Based on type, the seasonal affective disorder market is segmented into spring and summer SAD, fall and winter SAD, and others.

Based on diagnosis, the seasonal affective disorder market is segmented into psychological evaluation, lab tests, physical exam, and others. The lab test segment is further segmented into thyroid blood tests, complete blood count, and others. The psychological evaluation segment is again segmented into direct observation tests, vocational tests, neuropsychological tests, aptitude tests, achievement tests, attitude tests, personality tests, and intelligence tests.

Based on treatment, the seasonal affective disorder market is segmented into counselling, psychotherapy, medications, light therapy, and others. The medications segment has been further segmented into antidepressants and others. Antidepressants have been again segmented into reuptake inhibitors and others. The psychotherapy segment has further been segmented into gestalt therapy, existential psychotherapy, cognitive analytical therapy, body psychotherapy, behavioral therapy, attachment-based psychotherapy, art therapy, and others.

Based on end user, the seasonal affective disorder market is segmented into medical research centers, academic institutes, hospitals and clinics, and others.

Seasonal Affective Disorder Market Regional Analysis

By region, the seasonal affective disorder market report covers the latest trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will spearhead the market over the forecast period. This is owing to increasing awareness regarding different mental disorders and changing lifestyle. The US, South America, and Brazil are the key contributors in this region.

The seasonal affective disorder market in Europe is predicted to have a healthy growth over the forecast period. This is owing to the rising prevalence of seasonal affective disorder and severe depression. The UK, Ireland, Germany, and France are the key contributors in this region.

The seasonal affective disorder market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is owing to growing awareness, changing lifestyle, availability of products and treatments, and developing health facilities.

The seasonal affective disorder market in the Middle East and Africa will have a slow growth over the forecast period. This is owing to limited access to healthcare facilities, less awareness about seasonal affective disorder, and low prevalence rate. The countries in the Middle East are leading the market owing to rising expenditure on health and developed healthcare infrastructure.

Seasonal Affective Disorder Market Key Players

Key players profiled in the global seasonal affective disorder market report include Pfizer Inc. (US), Henry Schein, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb Company (US), Bayer AG (Germany), Allergan (Republic of Ireland), and AbbVie Inc. (US).

February 2019: Australia based medtech startup, Active Wearables has come up with a wearable, Pocket Sky that has been specially designed for combating conditions that result from poor access to sunlight and time shifts. This device can be used as glasses and emits blue light for emulating sunlight, and suppress melatonin production. Pocket Sky can aid with conditions which are based on restricted sunlight, including seasonal affective disorder and also problems with circadian rhythms, including shift work order and jetlag.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/seasonal-affective-disorder-market-4123

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Dermal Fillers Market : Analysed By Business Growth, Development Factors, Applications, Future Prospects and Forecast till 2023

Market Insight

Market reports associated with the healthcare sector has been released by Market Research Future. It states that the global dermal fillers market is set to expand at a higher CAGR during the forecast period until 2023. The inclusion of multiple dermal fillers over the years, along with its wide spectrum applications have bolstered the market growth substantially. According to the study of MRFR, the global dermal fillers market is currently being valued over USD 4,900 Mn, which is anticipated to spread in the forecast period backing with influential factors.

Market Drivers & Trends

The elevated demand dermal fillers for a facial aesthetic, which includes face-lift and facial line correction has been one of the primary factors for market growth. These procedures are highly practiced in developed countries that have boosted the market to expand considerably. Intensive efforts in research & development by aesthetic companies has don wonders for the global dermal fillers market growth. They have stood stronger to the growth of the market and are capitalizing the market at a steady pace.

The boost of the new materials, new techniques, and new filler devices are yet another essential driver to the market growth. Apart from this, the increased acceptance of tissue fillers, across the world, is favoring the market players and enhancing the market position. More positive notions about the growth of the market come in from increased sustainability of dermal fillers owing to the factors such as the expansion of geriatric population, rising disposable income and improved procedure quality and have paved ways for more new techniques to come in the future.

Furthermore, advances in surgical technology have also made such procedure safer and effective than ever before that has to bring fortune to the market position in the current years.

On the flip side, factors such as non-assurance of zero side-effects remain to be a key area of concern, and high cost of surgery and regulatory norms can also pose as formidable challenges for the market growth in the forecast period.

Market Segmentation

MRFR’s report includes a comprehensive segmental analysis of dermal fillers market based on types and application.

In terms of types: It includes botulinum toxin, hyaluronic acid, polymers & particles, and collagen. Among these, the botulinum toxin segment is probable to remain the most profitable segment with the expectation to reach a valuation of more than US$ 4600 by 2023-end. Whereas, the hyaluronic acid segment is anticipated to record the fastest growth rate during the assessment period.

In terms of application: It includes lip treatments, facial line correction treatment, face-lift, and MANY more. The facial line correction treatment segment, in 2016 has recorded to gain the largest market share and now was likely to reach a valuation more than US$ 4300 Mn by the year 2023. The face-lift segment is also likely to remain highly attractive since 2018 and beyond by having a vigorous CAGR of 12.8% from 2017 to 2023.

Detailed Regional Outlook

The global dermal fillers market study has covered across key regions like North America, Latin America, the Middle East & Africa (MEA) Europe and the Asia Pacific (APAC).

Among them, the Americas region is expected to remain a lucrative market for dermal fillers throughout the assessment period. In 2016, North America and Latin America communally captured more than one-third share of the market. Americas is then followed by Europe with the demand for facial aesthetics, as it is high in many of the European countries. This makes the region an important market for dermal fillers.

Europe’s region for dermal fillers market is likely to observe a double-digit CAGR during the forecast period. Asia Pacific’s market of dermal filler is also to witness the highest CAGR during the assessment period due to factors such as rising per-capita income, amplified acceptance of cosmetic procedures in countries of Asia Pacific and availability of more options of facial injectables.

Key Players

ALLERGAN, GALDERMA, Dr. Korman Laboratories, Integra Lifesciences, Merz Pharma, Sinclair Pharma, and Teoxane Laboratories are some of the top listed market players contributing to the global dermal fillers market remarkably.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Industry Analysis Reports | Health Care | Medical Devices | Pharmaceutical

Labels

Tuesday, 2 March 2021

Epilepsy Diagnosis & Treatment Market Global Opportunities, Development Status, Sales Revenue and Forecast 2023

Nurse Call System Market 2021 Size, Share, Growth, COVID-19 Impact Analysis, Business Opportunities, Demand by Major Companies

Breast Imaging Market, Industry Segments, Growth, Trends, Demand, Outlook by 2023

Coma Diagnosis & Treatment Market: Emerging Technologies, Competition & Strategies of Key Players, Regional Analysis and Forecast By 2023

Monday, 1 March 2021

Phototherapy Market Analysis, Industry Growth, Demand, Size, Share, Opportunities and Regional Forecast 2027

Regional demand on Seasonal Affective Disorder Market Analysis, size, News and Forecast

Dermal Fillers Market : Analysed By Business Growth, Development Factors, Applications, Future Prospects and Forecast till 2023

Blog Archive

Total Pageviews